name

Andrew Cohen

Counsel
Firm Logo

Patterson Belknap Webb & Tyler LLP

New York, USA
    Local Time: Monday 14:50

Practice Expertise

  • Alternative Dispute Resolution
  • Biotechnology
  • Complex Commercial Actions
  • Intellectual Property Litigation

Areas of Practice

  • Alternative Dispute Resolution
  • Biotechnology
  • Complex Commercial Actions
  • Intellectual Property Litigation
  • Litigation
  • Patent Litigation
  • View More

Profile

Andrew D. Cohen, Ph.D. is Counsel in the Firm’s Litigation department, where he focuses on patent litigation with an emphasis on the pharmaceutical and biotechnology industries. He represents clients in patent litigation on a variety of subject matters including small molecule chemistry, biologics, and medical devices. He has litigated cases brought under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA), and has represented clients in inter partes reviews (IPR). He maintains an active pro bono practice including civil rights litigation, housing disputes, and asylum applications. 

From 2012 to 2013, Mr. Cohen served as a law clerk to the Hon. Cathy Seibel of the United States District Court for the Southern District of New York. Prior to clerking, Mr. Cohen also spent three years as a patent agent at an international law firm, where he worked on motion practice, patent prosecution, due diligence, and opinion drafting. Before that, he was a scientific advisor for three years at a boutique intellectual property law firm, where he worked on several Hatch-Waxman litigations, as well as due diligence, opinion drafting and patent prosecution. Mr. Cohen was recognized as a Rising Star in the New York-Metro edition of Super Lawyers from 2017-2020.

Representative Experience:

  • Obtained a trial victory for a Fortune 100 pharmaceutical company in a Hatch-Waxman patent litigation following a multi-week virtual bench trial.  At stake was nearly 10 years of patent protection for a blockbuster medicine with over $1.5 billion in annual sales in the United States.
  • Represented a Fortune 500 biotechnology company in obtaining dismissal of a $530 million patent infringement suit regarding recombinant DNA expression vectors.
  • Represented multinational pharmaceutical company in one the first cases brought under the BPCIA involving a blockbuster antibody product and methods of manufacturing biologics.
  • Represented multinational pharmaceutical company against U.S. Customs in a bench trial, successfully obtaining judgment that the company’s blockbuster small-molecule drug can be imported duty-free.
  • Represented a pharmaceutical company in arbitration regarding small-molecule product royalties.

Bar Admissions

  • U.S. Supreme Court
  • U.S. Patent and Trademark Office
  • U.S. Court of Appeals, Federal Circuit
  • U.S. District Court, Southern District of New York
  • U.S. Court of International Trade
  • New York

Education

  • Fordham University School of Law (J.D., magna cum laude, 2012)
    • Order of the Coif
    • Senior Articles Editor, Fordham Law Review, Vol. 79
    • Wilkinson Scholar
  • Johns Hopkins University (Ph.D., 2006)
    • Chemistry (Organic)
  • Johns Hopkins University (M.A., 2004)
    • Chemistry (Organic)
  • Princeton University (A.B., cum laude, 2000)
    • Chemistry (Organic)

Areas of Practice

  • Alternative Dispute Resolution
  • Biotechnology
  • Complex Commercial Actions
  • Intellectual Property Litigation
  • Litigation
  • Patent Litigation

Professional Career


Professional Activities and Experience

MEMBERSHIPS: American Chemical Society; New York City Bar Association (Member of the Patents Committee); New York Intellectual Property Law Association (Member of the Amicus Briefs Committee).


Blogs

Antitrust Update

Antitrust Update Blog is a source of insights, information and analysis on criminal and civil antitrust and competition-related issues. Patterson Belknap’s antitrust lawyers represent clients in antitrust litigation and counseling matters, including those related to pricing, marketing, distribution, franchising, and joint ventures and other strategic alliances. We have significant experience with government civil and criminal/cartel investigations, providing the unique perspectives of former...

Biologics Blog

Biologics Blog is a source of insights, information and analysis related to biologics, including the legal developments, trends and changing regulation that impact the biotechnology industry. Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing and other contractual disputes. Our team includes highly experienced trial attorneys with extensive

Biologics Blog

Biologics Blog is a source of insights, information and analysis related to biologics, including the legal developments, trends and changing regulation that impact the biotechnology industry. Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing and other contractual disputes. Our team includes highly experienced trial attorneys with extensive...

Data Security Law Blog

DataSecurityLaw.com is the firm’s resource for the latest news, analysis, and thought leadership in the critical area of privacy and cybersecurity law. Patterson Belknap’s Privacy and Data Security practice provides public and private enterprises, their leadership teams and boards with comprehensive services in this critical area. Our team of experienced litigators, corporate advisors and former federal and state prosecutors advises on a broad range of privacy and data protection matters...

Misbranded

Misbranded is Patterson Belknap’s blog covering false advertising litigation—both consumer class actions and competitor suits—with a particular focus on FDA-regulated products (foods/beverages, pharmaceuticals, cosmetics, and dietary supplements).

New York Commercial Division Decisions

The blog is a source for insights and developments related to practice in the Commercial Division of the New York State Supreme Court. This blog reviews key developments in the Commercial Division, including important decisions handed down by the Commercial Division and appellate court decisions reviewing Commercial Division decisions. The blog also covers changes and proposed changes to Commercial Division rules and practice, including revisions to the rules since January 2015. The...

NY Patent Decisions Blog

NYPatentDecisionsBlog.com is a source for the latest patent decisions from the U.S. District Courts for the Southern and Eastern Districts of New York. The blog is authored by Patterson Belknap’s Patent Litigation practice group, whose members are highly experienced trial attorneys with extensive technical knowledge. Many have advanced scientific degrees and industry experience in fields such as communications, electrical and electro-optical technology, semiconductor technology, metallurgical...

Meet our Firms and Professionals

WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.